Review
Nature Reviews Drug Discovery 7, 517-529 (June 2008) | doi:10.1038/nrd2588
Form to function: current and future roles for atherosclerosis imaging in drug development
Alistair C. Lindsay1 & Robin P. Choudhury1 About the authors
Abstract
There is a pressing need for robust imaging markers to assist in the development of drugs for the treatment of atherosclerosis. Conventional imaging methods provide quantitative and morphological data but may be inadequate for assessing a new generation of therapies that modify plaque biology directly. Here, we compare the main imaging modalities used to image atherosclerosis in the clinical-trial setting, and assess their ability to predict clinical outcomes for a given sample size. We consider how emerging molecular and cellular imaging techniques could offer the possibility to quantify changes in biological function at the level of the plaque, even without gross structural change.
- View At a Glance
Author affiliations
- Department of Cardiovascular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK.
Correspondence to: Robin P. Choudhury1 Email: robin.choudhury@cardiov.ox.ac.uk
Published online 16 May 2008
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Arithmetic of vulnerable plaques for noninvasive imagingNature Clinical Practice Cardiovascular Medicine Article (01 Aug 2008)
See all 24 matches for Research
